NVO - Spark Newswire

1 minute read

President Biden Tweets ‘Right now, there’s a kid out there whose family can’t afford her insulin because it costs $1,000 per month. The Build Back Better Act would cap their monthly insulin costs at $35. I’m committed as ever to getting it done for the…

By Benzinga Newsdesk

Today, 1:59 PM

https://twitter.com/POTUS/status/1472983210665590785

NVO

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For December 20, 2021

By Benzinga Insights

Today, 1:59 PM

ANTM

2 minute read

This Is What Whales Are Betting On Novo Nordisk

By Benzinga Insights

Today, 1:59 PM

Someone with a lot of money to spend has taken a bearish stance on Novo Nordisk (NYSE:NVO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

NVO

1 minute read

Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades

By Vandana Singh

Today, 1:59 PM

Novo Nordisk A/S (NYSE: NVO) said that a contract manufacturer filling syringes for pens to inject Wegovy (semaglutide) had

NVO

1 minute read

JP Morgan Downgrades Novo Nordisk to Neutral

By Benzinga Newsdesk

Today, 1:59 PM

JP Morgan analyst Richard Vosser downgrades Novo Nordisk (NYSE:NVO) from Overweight to Neutral.

NVO

2 minute read

News

Novo Nordisk Invests More than DKK 17B ($2.6B) in Expansion of Manufacturing Facilities in Kalundborg, Denmark

By Charles Gross

Today, 1:59 PM

Novo Nordisk today announced plans to invest more than 17 bn Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its production site in Kalundborg, Denmark.

NVO

5 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:59 PM

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

3 minute read

Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher

By Lisa Levin

Today, 1:59 PM

Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80.

ASYS

4 minute read

44 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 1:59 PM

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.

AEHR

1 minute read

Novo Nordisk Reports Ozempic 2.0mg Recommended For Approval For Treatment Of Type 2 Diabetes By European Medicines Agency

By Benzinga Newsdesk

Today, 1:59 PM

https://www.globenewswire.com/news-release/2021/11/12/2333189/0/en/Ozempic-2-0-mg-recom[…]ype-2-diabetes-by-the-European-Medicines-Agency.html?pdf=1

NVO

Feed Symbols: NVO